Pacira BioSciences (PCRX) Restructuring Costs (2022 - 2025)

Pacira BioSciences' Restructuring Costs history runs 4 years deep, the most recent figure standing at $851000.0 for Q4 2025.

• In Q4 2025, Restructuring Costs fell 82.38% year-over-year to $851000.0; the TTM figure through Dec 2025 stood at $14.5 million (up 87.78% YoY), while the FY2025 annual figure was $14.1 million, up 83.23% from the prior year.
• Restructuring Costs was $851000.0 for Q4 2025 at Pacira BioSciences, down from $6.8 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $10.9 million in Q4 2022 to a low of -$1.8 million in Q3 2024.
• Historically, Restructuring Costs has averaged $2.7 million across 4 years, with a median of $1.4 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Restructuring Costs tumbled 983.0% in 2024, then jumped 484.54% in 2025.
• A 4-year view of Restructuring Costs shows it stood at $10.9 million in 2022, then tumbled by 113.32% to -$1.5 million in 2023, then jumped by 432.64% to $4.8 million in 2024, then slumped by 82.38% to $851000.0 in 2025.
• The last three Restructuring Costs figures came in at $851000.0 (Q4 2025), $6.8 million (Q3 2025), and $634000.0 (Q2 2025), per Business Quant data.